Canine
Blind case validation of the frozen Canine candidate across normal variation, learning/routine, hidden medical relevance, safety/aggression/welfare, conflicting data and complex multidomain cases.
LHINOS Research Lab
LHINOS Animal Intelligence — External Validation
Independent blind validation of frozen canine and equine SHADOW research candidates.
Review mode: asynchronous expert review by email; no product launch, clinical claim or autonomous high-risk intervention is implied.
Research objective
Independent external validation of frozen LHINOS Animal candidates in SHADOW research mode. The immediate question is whether outputs remain safe, restrained and useful on previously unseen cases scored by qualified independent experts.
Scope
Equine
External equine behaviour and welfare validation after the frozen candidate payload, manifest and checksum are independently reconstructable and fixed before testing.
Validation principles
- No system validates itself.
- No mid-run prompt tuning or re-prompting during blind evaluation.
- Independent case authorship, scoring and adjudication should be separated where possible.
- Medical relevance, safety, welfare, uncertainty, referral calibration and restraint/no-intervention decisions are explicit review dimensions.
- No veterinary diagnosis claim and no autonomous high-risk animal intervention are in scope.
Requested written response
- Are the blind-validation design and reviewer-role separation scientifically appropriate?
- Which safety, welfare or medical-boundary failures should be treated as critical?
- Which case families or adversarial framings are missing?
- What evidence would be required before any claim beyond SHADOW research could be justified?
- Would you recommend changes to reviewer scoring, adjudication or contamination controls?
Written review by email is sufficient for the first step.
Public review brief
A concise, externally suitable research brief is available for download and forwarding.
This research room does not imply scientific validation, endorsement, certification, production readiness, clinical capability or institutional commitment.